A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study (Q86853989)
Jump to navigation
Jump to search
scientific article published on 19 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study |
scientific article published on 19 April 2013 |
Statements
A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study (English)
Thomas J Povsic
Candice Junge
Adel Nada
Richard A Schatz
Robert A Harrington
Charles J Davidson
F David Fortuin
Farrell O Mendelsohn
Warren Sherman
Gary L Schaer
Christopher J White
Duncan Stewart
Kenneth Story
Douglas W Losordo
Timothy D Henry